Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

1.23% fluoride foam application

100mg aspirin

100mg diclofenac

18F-FDG

18F-P3BZA

18F-PMPBB3 (APN-1607) PET imaging

18F-PSMA-1007

25% Carbohydrate solution (CHO drinking)

2L PEG

3T MR Imaging of the cervical spinal cord

5-gene classification model

68Ga-DOTA-NT-20.3

68Ga-Her2-affibody

68Ga-pentixafor

7 g Ispaghula

75 mg acetylsalicylic acid

89Zr-KN035

99mTc-4BOH SPECT myocardial perfusion imaging

99mTc-H7ND SPECT/CT imaging performed

99mTc-pyrophosphate Scintigraphy

A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).

A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

A+ HA(tm)

AIM-CHD Mobile Health Intervention

Frequently asked questions